Varex Imaging (VREX) Panoramica del titolo
Varex Imaging Corporation progetta, produce e vende componenti di imaging a raggi X. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 6/6 |
| Crescita futura | 3/6 |
| Prestazioni passate | 0/6 |
| Salute finanziaria | 3/6 |
| Dividendi | 0/6 |
Premi
Analisi del rischio
VREX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di Varex Imaging Corporation
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | US$11.53 |
| Massimo di 52 settimane | US$14.57 |
| Minimo di 52 settimane | US$6.76 |
| Beta | 0.96 |
| Variazione di 1 mese | 9.81% |
| Variazione a 3 mesi | -17.23% |
| Variazione di 1 anno | 39.59% |
| Variazione a 3 anni | -47.09% |
| Variazione a 5 anni | -51.94% |
| Variazione dall'IPO | -57.72% |
Notizie e aggiornamenti recenti
VREX: Future Upside Will Depend On Q2 2026 Revenue And Margin Delivery
Analysts recently raised their price target on Varex Imaging by $2. This change reflects updated views on revenue growth, profit margin potential, and a lower assumed future P/E multiple, while keeping fair value estimates unchanged.
VREX: Refined Discount Rate And P/E Assumptions Will Support Future Repricing
Analysts recently raised their price target on Varex Imaging by $2, reflecting updated assumptions on discount rate, profit margin, and future P/E. They see these assumptions as better aligned with the company’s risk and earnings profile.VREX: Higher Profitability Assumptions Will Support A Repriced Earnings Multiple
Analysts have raised their average price target for Varex Imaging by $1, reflecting updated views on fair value, profitability assumptions, and P/E expectations cited in recent research, including the latest move from B. Riley.VREX: Future Returns Will Hinge On Executing Q2 2026 Revenue Guidance
Narrative Update on Varex Imaging Analysts have lifted their price target on Varex Imaging by $2, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E that support a refreshed view of the company’s valuation profile. Analyst Commentary Even with the updated price target, some bearish analysts remain cautious.VREX: Future Returns Will Depend On Delivering Q2 2026 Guidance Execution
Analysts have lifted their price target on Varex Imaging to $16.0 from $14.5, citing updated assumptions around fair value, discount rate, revenue, profit margin and future P/E following recent research that included a $2 increase in target price at B. Riley.Recent updates
VREX: Future Upside Will Depend On Q2 2026 Revenue And Margin Delivery
Analysts recently raised their price target on Varex Imaging by $2. This change reflects updated views on revenue growth, profit margin potential, and a lower assumed future P/E multiple, while keeping fair value estimates unchanged.VREX: Refined Discount Rate And P/E Assumptions Will Support Future Repricing
Analysts recently raised their price target on Varex Imaging by $2, reflecting updated assumptions on discount rate, profit margin, and future P/E. They see these assumptions as better aligned with the company’s risk and earnings profile.VREX: Higher Profitability Assumptions Will Support A Repriced Earnings Multiple
Analysts have raised their average price target for Varex Imaging by $1, reflecting updated views on fair value, profitability assumptions, and P/E expectations cited in recent research, including the latest move from B. Riley.VREX: Future Returns Will Hinge On Executing Q2 2026 Revenue Guidance
Narrative Update on Varex Imaging Analysts have lifted their price target on Varex Imaging by $2, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E that support a refreshed view of the company’s valuation profile. Analyst Commentary Even with the updated price target, some bearish analysts remain cautious.VREX: Future Returns Will Depend On Delivering Q2 2026 Guidance Execution
Analysts have lifted their price target on Varex Imaging to $16.0 from $14.5, citing updated assumptions around fair value, discount rate, revenue, profit margin and future P/E following recent research that included a $2 increase in target price at B. Riley.VREX: Future Returns Will Balance Q4 Beat Against Ongoing Execution Risks
Analysts have revised their fair value estimate for Varex Imaging to $14.50 from $12.00, citing updated assumptions on the discount rate, revenue growth, profit margins and future P/E. This follows recent research that included a lower Street price target of $18 from $23, after Q4 revenue of $229M came in above prior estimates and guidance.It Looks Like Varex Imaging Corporation's (NASDAQ:VREX) CEO May Expect Their Salary To Be Put Under The Microscope
Feb 05
VREX: Future Returns Will Reflect Cautious Stance After Lowered Price Outlook
Narrative Update Analysts have trimmed their price target on Varex Imaging by $5 to $18, citing recent Q4 revenue of $229M coming in above their estimates and within guidance, along with Q1 2026 revenue guidance of $200M to $215M that aligns closely with current expectations. Analyst Commentary Bearish analysts are reacting to the recent update by trimming their expectations, even as the latest numbers line up with prior guidance and estimates.VREX: Future Returns Will Reflect Trimmed Outlook After Q1 2026 Revenue Guidance
Narrative Update on Varex Imaging The analyst consensus price target for Varex Imaging has shifted to US$18 from US$23, with analysts pointing to the recent Q4 revenue outcome of US$229m versus prior expectations and the Q1 2026 guidance range of US$200m to US$215m as key inputs behind the revision. Analyst Commentary Bearish analysts have responded to the latest results and guidance by trimming their expectations, even though the recent Q4 revenue outcome of US$229m sat at the high end of management's US$210m to US$230m range and ahead of prior estimates.Is Varex Imaging (NASDAQ:VREX) A Risky Investment?
Jan 09VREX: Future Performance Will Reflect Trimmed Outlook Amid Solid Recent Results
Analysts have trimmed their price target on Varex Imaging to $18 from $23, citing slightly softer long term growth assumptions, despite recent quarterly revenues and forward guidance coming in ahead of or in line with prior expectations. Analyst Commentary Bearish analysts acknowledge Varex Imaging's better than expected quarterly performance and solid positioning within its end markets, but remain cautious on the durability of growth and the balance of risk and reward at current levels.Varex Imaging Corporation (NASDAQ:VREX) Shares Could Be 35% Below Their Intrinsic Value Estimate
Nov 20Varex Imaging Corporation (NASDAQ:VREX) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 10The Returns At Varex Imaging (NASDAQ:VREX) Aren't Growing
Aug 06Calculating The Intrinsic Value Of Varex Imaging Corporation (NASDAQ:VREX)
Jul 19These 4 Measures Indicate That Varex Imaging (NASDAQ:VREX) Is Using Debt Extensively
Jun 10Earnings Beat: Varex Imaging Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
May 11Lacklustre Performance Is Driving Varex Imaging Corporation's (NASDAQ:VREX) 32% Price Drop
Apr 25Little Excitement Around Varex Imaging Corporation's (NASDAQ:VREX) Revenues As Shares Take 32% Pounding
Apr 25Be Wary Of Varex Imaging (NASDAQ:VREX) And Its Returns On Capital
Apr 04Varex Imaging Corporation: A Mixed Picture
Jan 21Varex Imaging (NASDAQ:VREX) Is Finding It Tricky To Allocate Its Capital
Dec 19There's Reason For Concern Over Varex Imaging Corporation's (NASDAQ:VREX) Massive 29% Price Jump
Nov 07Does Varex Imaging (NASDAQ:VREX) Have A Healthy Balance Sheet?
Oct 22
Expanding In India And Innovating In Photon Technology Boosts Prospects Despite Challenges In China And Semiconductor Softness
Expansion into India and focus on photon counting technology aim to recover market share in radiographic and dental sectors, potentially increasing revenue.Varex Imaging: Headroom Capped Without Higher Earnings On Capital Employed
Sep 11Little Excitement Around Varex Imaging Corporation's (NASDAQ:VREX) Earnings
Aug 20We Like Varex Imaging's (NASDAQ:VREX) Earnings For More Than Just Statutory Profit
May 10Varex Imaging Corporation: The Picture Is Cloudy After Quarterly Results
Feb 07We Like These Underlying Return On Capital Trends At Varex Imaging (NASDAQ:VREX)
Dec 14Is Varex Imaging (NASDAQ:VREX) A Risky Investment?
Nov 05Rendimenti per gli azionisti
| VREX | US Medical Equipment | US Mercato | |
|---|---|---|---|
| 7D | -4.5% | -5.0% | 0.6% |
| 1Y | 39.6% | -19.0% | 28.4% |
Ritorno vs Industria: VREX ha superato il US Medical Equipment che ha restituito -19 % nell'ultimo anno.
Rendimento vs Mercato: VREX ha superato il mercato US che ha restituito 28.4 % nell'ultimo anno.
Volatilità dei prezzi
| VREX volatility | |
|---|---|
| VREX Average Weekly Movement | 5.7% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.2% |
Prezzo delle azioni stabile: VREX non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato US.
Volatilità nel tempo: La volatilità settimanale ( 6% ) di VREX è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 2016 | 2,400 | Sunny Sanyal | www.vareximaging.com |
Varex Imaging Corporation progetta, produce e vende componenti per radiografie. Opera attraverso due segmenti, Medicale e Industriale. Il segmento Medicale progetta, produce, vende e assiste componenti di imaging a raggi X, tra cui tubi a raggi X, rivelatori digitali e accessori, camere di ionizzazione, connettori ad alta tensione, software di elaborazione delle immagini e workstation, software di ricostruzione 3D, software diagnostico assistito da computer, collimatori, dispositivi di controllo automatico dell'esposizione, generatori e scambiatori di calore.
Varex Imaging Corporation Riepilogo dei fondamenti
| VREX statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | US$486.68m |
| Utili (TTM) | -US$67.70m |
| Ricavi(TTM) | US$854.40m |
VREX è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| VREX Conto economico (TTM) | |
|---|---|
| Ricavi | US$854.40m |
| Costo del fatturato | US$562.60m |
| Profitto lordo | US$291.80m |
| Altre spese | US$359.50m |
| Utili | -US$67.70m |
Ultimi utili riportati
Jan 02, 2026
Prossima data di guadagno
May 07, 2026
| Utile per azione (EPS) | -1.62 |
| Margine lordo | 34.15% |
| Margine di profitto netto | -7.92% |
| Rapporto debito/patrimonio netto | 74.9% |
Come si è comportato VREX nel lungo periodo?
Vedi performance storica e confrontoAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/05/05 01:57 |
| Prezzo dell'azione a fine giornata | 2026/05/05 00:00 |
| Utili | 2026/01/02 |
| Utili annuali | 2025/10/03 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Varex Imaging Corporation è coperta da 9 analisti. 5 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Anderson Schock | B. Riley Securities, Inc. |
| Lawrence Solow | CJS Securities, Inc. |
| Rajbir Denhoy | Jefferies LLC |